Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Imaging of neuroinflammation in Alzheimer's disease, multiple sclerosis and stroke: Recent developments in positron emission tomography.
Generation of an immortalized murine brain microvascular endothelial cell line as an in vitro blood brain barrier model.
[Sociological research in Samara Oblast: a role of social organizations of patients in the improvement of quality of medical and social care].
"People power" or "pester power"? YouTube as a forum for the generation of evidence and patient advocacy.
Sphingolipids in ocular inflammation.
Dark microglia: A new phenotype predominantly associated with pathological states.
Epitope-specific CD8+ T cells play a differential pathogenic role in the development of a viral disease model for multiple sclerosis.
[Recurring neuromyelitis without optic neuritis: a case report].
Future MS care: a consensus statement of the MS in the 21st Century Steering Group.
Setting new standards in multiple sclerosis care and research.
Inducible Foxp3+ regulatory T-cell development by a commensal bacterium of the intestinal microbiota.
The effects of aquatic therapy on mobility of individuals with neurological diseases: A systematic review.
Immune-Reconstitution Inflammatory Syndrome in Multiple Sclerosis Patients Treated With Natalizumab: A Series of 4 Cases.
Brain metabolic changes suggestive of axonal damage in radiologically isolated syndrome.
Segmentation of Multiple Sclerosis Lesions in Brain MR Images Using Spatially Constrained Possibilistic Fuzzy C-Means Classification.
Evaluating treatment effect within a multivariate stochastic ordering framework: Nonparametric combination methodology applied to a study on multiple sclerosis.
Origin and differentiation of microglia.
Balò's concentric sclerosis: still to be considered as a variant of multiple sclerosis?
Aggressive multiple sclerosis: proposed definition and treatment algorithm.
Behçet's disease patients with multiple sclerosis-like features: discriminative value of Barkhof criteria.
Safety and efficacy of fingolimod in clinical practice: The experience of an academic center in the Middle East.
Multiple sclerosis: Etiology, symptoms, incidence and prevalence, and implications for community living and employment.
The changing clinical course of multiple sclerosis: A matter of grey matter.
Multiple sclerosis: On the TRAIL of IFN-β response.
Profile of Circulatory Metabolites in a Relapsing-remitting Animal Model of Multiple Sclerosis using Global Metabolomics.

Pages